Compare ITI Pharma and Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
1.0
5.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.35
1.86
NAV
₹15.59
₹37.96
Fund Started
18 Oct 2021
25 Jun 2018
Fund Size
₹210.46 Cr
₹6658.41 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 1% if redeemed within 15 days.
1 Year
3.67%
8.03%
3 Year
20.57%
27.09%
5 Year
-
16.93%
Equity
98.24%
97.60%
Cash
1.76%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.76% |
Divi's Laboratories Ltd. | 8.96% |
Apollo Hospitals Enterprise Ltd. | 6.21% |
Max Healthcare Institute Ltd. | 5.49% |
Torrent Pharmaceuticals Ltd. | 4.98% |
Aurobindo Pharma Ltd. | 4.55% |
Lupin Ltd. | 3.69% |
Fortis Healthcare Ltd. | 3.66% |
Alkem Laboratories Ltd. | 3.36% |
Aster DM Healthcare Ltd. | 2.81% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
18 Oct 2021
25 Jun 2018
